<DOC>
	<DOCNO>NCT00499200</DOCNO>
	<brief_summary>The study include preliminary pharmacokinetics ( PK ) / safety / tolerability evaluation healthy elderly subject follow Receptor Occupancy ( RO ) evaluations healthy elderly subject Alzheimer 's Disease ( AD ) subject .</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability , Pharmacokinetics 5 HT1A Receptor Occupancy</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion criterion : Men woman 60 year age screening . Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign , 12lead electrocardiogram ( ECG ) . Exclusion criterion : History drug abuse within 1 year study day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>